BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

309 related articles for article (PubMed ID: 18362895)

  • 1. Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice.
    Cunha TM; Barsante MM; Guerrero AT; Verri WA; Ferreira SH; Coelho FM; Bertini R; Di Giacinto C; Allegretti M; Cunha FQ; Teixeira MM
    Br J Pharmacol; 2008 May; 154(2):460-70. PubMed ID: 18362895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DF2755A, a novel non-competitive allosteric inhibitor of CXCR1/2, reduces inflammatory and post-operative pain.
    Lopes AH; Brandolini L; Aramini A; Bianchini G; Silva RL; Zaperlon AC; Verri WA; Alves-Filho JC; Cunha FQ; Teixeira MM; Allegretti M; Cunha TM
    Pharmacol Res; 2016 Jan; 103():69-79. PubMed ID: 26592483
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature.
    Coelho FM; Pinho V; Amaral FA; Sachs D; Costa VV; Rodrigues DH; Vieira AT; Silva TA; Souza DG; Bertini R; Teixeira AL; Teixeira MM
    Arthritis Rheum; 2008 Aug; 58(8):2329-37. PubMed ID: 18668539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the chemokine receptor CXCR2 ameliorates adjuvant-induced arthritis in rats.
    Barsante MM; Cunha TM; Allegretti M; Cattani F; Policani F; Bizzarri C; Tafuri WL; Poole S; Cunha FQ; Bertini R; Teixeira MM
    Br J Pharmacol; 2008 Mar; 153(5):992-1002. PubMed ID: 17891165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor.
    Bertini R; Barcelos LS; Beccari AR; Cavalieri B; Moriconi A; Bizzarri C; Di Benedetto P; Di Giacinto C; Gloaguen I; Galliera E; Corsi MM; Russo RC; Andrade SP; Cesta MC; Nano G; Aramini A; Cutrin JC; Locati M; Allegretti M; Teixeira MM
    Br J Pharmacol; 2012 Jan; 165(2):436-54. PubMed ID: 21718305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophils recruited by CXCR1/2 signalling mediate post-incisional pain.
    Carreira EU; Carregaro V; Teixeira MM; Moriconi A; Aramini A; Verri WA; Ferreira SH; Cunha FQ; Cunha TM
    Eur J Pain; 2013 May; 17(5):654-63. PubMed ID: 23132735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-17 mediates articular hypernociception in antigen-induced arthritis in mice.
    Pinto LG; Cunha TM; Vieira SM; Lemos HP; Verri WA; Cunha FQ; Ferreira SH
    Pain; 2010 Feb; 148(2):247-256. PubMed ID: 19969421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
    Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
    J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological characterization of Sch527123, a potent allosteric CXCR1/CXCR2 antagonist.
    Gonsiorek W; Fan X; Hesk D; Fossetta J; Qiu H; Jakway J; Billah M; Dwyer M; Chao J; Deno G; Taveras A; Lundell DJ; Hipkin RW
    J Pharmacol Exp Ther; 2007 Aug; 322(2):477-85. PubMed ID: 17496166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental Arthritis.
    Oliveira MC; Tavares LP; Vago JP; Batista NV; Queiroz-Junior CM; Vieira AT; Menezes GB; Sousa LP; van de Loo FA; Teixeira MM; Amaral FA; Ferreira AV
    PLoS One; 2016; 11(1):e0146403. PubMed ID: 26742100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
    Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
    Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A crucial role for TNF-alpha in mediating neutrophil influx induced by endogenously generated or exogenous chemokines, KC/CXCL1 and LIX/CXCL5.
    Vieira SM; Lemos HP; Grespan R; Napimoga MH; Dal-Secco D; Freitas A; Cunha TM; Verri WA; Souza-Junior DA; Jamur MC; Fernandes KS; Oliver C; Silva JS; Teixeira MM; Cunha FQ
    Br J Pharmacol; 2009 Oct; 158(3):779-89. PubMed ID: 19702783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of cytokines in mediating mechanical hypernociception in a model of delayed-type hypersensitivity in mice.
    Cunha TM; Verri WA; Valério DA; Guerrero AT; Nogueira LG; Vieira SM; Souza DG; Teixeira MM; Poole S; Ferreira SH; Cunha FQ
    Eur J Pain; 2008 Nov; 12(8):1059-68. PubMed ID: 18372199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crucial role of neutrophils in the development of mechanical inflammatory hypernociception.
    Cunha TM; Verri WA; Schivo IR; Napimoga MH; Parada CA; Poole S; Teixeira MM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2008 Apr; 83(4):824-32. PubMed ID: 18203872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunomodulatory oligonucleotides inhibit neutrophil migration by decreasing the surface expression of interleukin-8 and leukotriene B4 receptors.
    Admyre C; Axelsson LG; von Stein O; Zargari A
    Immunology; 2015 Feb; 144(2):206-17. PubMed ID: 25100544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.
    Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M
    J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
    Li F; Zhang X; Gordon JR
    Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The CXCL8/IL-8 chemokine family and its receptors in inflammatory diseases.
    Russo RC; Garcia CC; Teixeira MM; Amaral FA
    Expert Rev Clin Immunol; 2014 May; 10(5):593-619. PubMed ID: 24678812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNF-alpha and IL-1beta mediate inflammatory hypernociception in mice triggered by B1 but not B2 kinin receptor.
    Cunha TM; Verri WA; Fukada SY; Guerrero AT; Santodomingo-Garzón T; Poole S; Parada CA; Ferreira SH; Cunha FQ
    Eur J Pharmacol; 2007 Nov; 573(1-3):221-9. PubMed ID: 17669394
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Porcine CXCR1/2 antagonist CXCL8
    Wang X; Li Y; Li L; Jiao Z; Liu X; Cheng G; Gu C; Hu X; Zhang W
    Sci Rep; 2020 Jan; 10(1):1210. PubMed ID: 31988368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.